Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Aug 4;89(3):437-54.
doi: 10.1038/sj.bjc.6601106.

Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK

D R Newell  1 , K M Searle, N B Westwood, S S Burtles; Cancer Research UK Phase I/II Clinical Trials Committee
Affiliations

Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK

D R Newell et al. Br J Cancer. .
No abstract available

PubMed Disclaimer

Comment in

  • Celebrating novel cancer drugs.
    Weiss RA. Weiss RA. Br J Cancer. 2003 Aug 4;89(3):425. doi: 10.1038/sj.bjc.6601229. Br J Cancer. 2003. PMID: 12888806 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

References

    1. Aboagye EO, Kelson AB, Tracy M, Workman P (1998) Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazoly) acetamide (SR-4554, CRC 94/17): a noninvasive diagnostic probe for the measurement of tumour hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography. Anti-Cancer Drug Des 13: 703–730 - PubMed
    1. Aboagye EO, Maxwell RJ, Kelson A, Tracy M, Lewis AD, Graham MA, Horsman M, Griffiths JR, Workman P (1997) Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia. Cancer Res 57: 3314–3318 - PubMed
    1. Adams GE, Flockhart IR, Smithen CE, Stratford IJ, Wardman P, Watts ME (1977) Electron-affinic sensitization VII: a correlation between structures, one-electron potentials and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat Res 67: 9–20 - PubMed
    1. Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I, West C (2001) Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 7 (4): 928–934 - PubMed
    1. Armstrong AC, Dermime S, Allinson CG, Bhattacharyya T, Mulryan K, Gonzalez KR, Stern PL, Hawkins RE (2002) Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope. J Immunol 168: 3983–3991 - PubMed

MeSH terms

Substances

Personal name as subject